Langford Ranks as Fastest Growing Community in B.C.
One Greater Victoria municipality led all B.C. communities with more 5,000 in population growth last year.
Langford added almost 2,100 people between 2018 and 2019 as its population grew by 5.2 per cent to 42,653, according to new population estimates. Three of Langford’s neighbouring West Shore municipalities also recorded considerable growth. Colwood grew by three per cent to 18,867, View Royal grew by 2.5 per cent to 11,567, and Sooke grew by 2.5 per cent to 14,657.
In fact, Langford, Colwood, View Royal and Sooke all made the Top 10 list of fastest growing communities above 5,000 people, further confirmation that the western communities of Greater Victoria are experiencing a population boom. By contrast, the two largest communities in the region, Victoria and Saanich recorded lower rates of growth at 1.9 per cent and 1.5 per cent respectively, growing to 94,005 and 122,173 residents respectively. Nanaimo retained its status as Vancouver Island’s largest community north of the Malahat with a population of 99,856 after growing at a rate of 1.4 per cent in 2019 compared to 2018.
Looking the 10 slowest growing communities above 5,000 residents, Oak Bay’s population stagnated between 2018 and 2019, officially adding just four residents. Esquimalt’s population, meanwhile, dropped by 0.2 per cent to 18,716. Pitt Meadows (minus 0.8 per cent), Kitimat (down 2.1 per cent) and Squamish (down 2.9 per cent) found themselves at the very bottom of the list.
The Capital Regional District as a whole grew by 1.5 per cent between 2018 and 2019 to 418,511 residents.
Looking at the provincial picture, B.C.’s estimated population as July 1, 2019 stood at 5,071 million with considerable regional variation in terms of population growth and decline.
While the Fraser Valley (up 2.1 per cent) and Central Okanagan (up 1.9 per cent) recorded the highest relative increases, the Northern Rockies Regional District (down four per cent) Squamish-Lillooet Regional District (down 0.6 per cent) and Stikine (down 0.1 per cent) recorded the largest relative decreases.
By Wolf Depner